These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 11837283)

  • 21. The ethics of single blind trials.
    Heckerling PS
    IRB; 2005; 27(4):12-6. PubMed ID: 16220629
    [No Abstract]   [Full Text] [Related]  

  • 22. [Regulations of the ethical evaluation system of scientific and clinical research in connection with Poland joining the European Union].
    Raszeja S
    Arch Med Sadowej Kryminol; 2004; 54(2-3):151-4. PubMed ID: 15495560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Researchers facing increasing costs for clinical research, with few solutions.
    Erdmann J
    J Natl Cancer Inst; 2005 Oct; 97(20):1492-4. PubMed ID: 16234558
    [No Abstract]   [Full Text] [Related]  

  • 24. What is the role of the research ethics committee? Paternalism, inducements, and harm in research ethics.
    Garrard E; Dawson A
    J Med Ethics; 2005 Jul; 31(7):419-23. PubMed ID: 15994364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Module five: implementation of ethics review.
    Dhai A
    Dev World Bioeth; 2005 Mar; 5(1):73-91. PubMed ID: 15748179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Guide to decision-making in institutional review of proposals for human experimentation.
    Himmelsbach CK
    Man Med; 1978; 3(3):201-220. PubMed ID: 12085911
    [No Abstract]   [Full Text] [Related]  

  • 27. Third-party risks in research: should IRBs address them?
    Hausman DM
    IRB; 2007; 29(3):1-5. PubMed ID: 17847635
    [No Abstract]   [Full Text] [Related]  

  • 28. Ethical considerations in clinical trials: invited remarks.
    Fletcher JC; Branson R; Freireich EJ
    Clin Pharmacol Ther; 1979 May; 25(5 Pt 2):742-6. PubMed ID: 373966
    [No Abstract]   [Full Text] [Related]  

  • 29. Empirical data and the acceptability of research risk: a commentary on the charitable participation standard.
    Reynolds WW; Nelson RM
    Arch Pediatr Adolesc Med; 2008 Jan; 162(1):88-90. PubMed ID: 18180419
    [No Abstract]   [Full Text] [Related]  

  • 30. Registering clinical trials in India: a scientific and ethical imperative.
    Tharyan P; Ghersi D
    Natl Med J India; 2008; 21(1):31-4. PubMed ID: 18472701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protecting the vulnerable in brain research.
    Cook-Deegan RM
    Cerebrum; 2000; 2(2):73-91. PubMed ID: 15986545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A pilot seminar on ethical issues in clinical trials for cancer researchers in Vietnam.
    Love RR; Fost N
    IRB; 2003; 25(6):8-10. PubMed ID: 15035249
    [No Abstract]   [Full Text] [Related]  

  • 33. The role of institutional review boards in protecting human subjects: are we really ready to fix a broken system?
    Beh HG
    Law Psychol Rev; 2002; 26(1):1-47. PubMed ID: 16514756
    [No Abstract]   [Full Text] [Related]  

  • 34. More Chinese get free drugs in clinical trials.
    Berton E
    Wall St J (East Ed); 2006 Feb; ():B1, B8. PubMed ID: 16528877
    [No Abstract]   [Full Text] [Related]  

  • 35. When "minimal risk" research yields clinically-significant data, maybe the risks aren't so minimal.
    Sharp HM; Orr RD
    Am J Bioeth; 2004; 4(2):W32-6. PubMed ID: 15186687
    [TBL] [Abstract][Full Text] [Related]  

  • 36. European Union clinical trials directive.
    Bull Med Ethics; 2001 Jul; (169):13-24. PubMed ID: 11878337
    [No Abstract]   [Full Text] [Related]  

  • 37. Case study: agency says institutional review board (IRB) did not fulfill duties so agency investigation expands.
    Maloney DM
    Hum Res Rep; 2006 Apr; 21(4):6-7. PubMed ID: 16832919
    [No Abstract]   [Full Text] [Related]  

  • 38. The ethics of clinical trials: to inform or not inform? That is the question.
    Spence EH
    Prof Ethics; 1998; 6(3-4):173-84. PubMed ID: 11838496
    [No Abstract]   [Full Text] [Related]  

  • 39. How some patients in new-drug trials can get cut off.
    Anand G
    Wall St J (East Ed); 2003 Dec; ():A1, A11. PubMed ID: 14971381
    [No Abstract]   [Full Text] [Related]  

  • 40. Individual responder analyses for pain: does one dose fit all?
    Mather LE
    Trends Pharmacol Sci; 2005 Nov; 26(11):544-5. PubMed ID: 16165226
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.